Print Page  |  Close Window

SEC Filings

8-K
CHROMADEX CORP. filed this Form 8-K on 03/07/2019
Entire Document
 
 
 
ChromaDex Corporation and Subsidiaries
 
 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Statements of Operations
 
 
 
 
 
 
Years Ended December 31, 2018 and December 30, 2017
 
 
 
 
 
 
(In thousands, except per share data)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018
 
 
2017
 
 
 
 
 
 
 
 
Sales, net
 $31,557 
 $21,201 
Cost of sales
  15,502 
  10,724 
 
    
    
Gross profit
  16,055 
  10,477 
 
    
    
Operating expenses:
    
    
Sales and marketing
  16,537 
  4,459 
Research and development
  5,478 
  4,007 
General and administrative
  27,137 
  17,642 
Other
  75 
  746 
Operating expenses
  49,227 
  26,854 
 
    
    
Operating loss
  (33,172)
  (16,377)
 
    
    
Nonoperating expense:
    
    
Interest expense, net
  (79)
  (153)
Other
  (65)
  - 
Nonoperating expenses
  (144)
  (153)
 
    
    
Loss from continuing operations
  (33,316)
  (16,530)
 
    
    
Loss from discontinued operations
  - 
  (315)
Gain on sale of discontinued operations
  - 
  5,467 
Income from discontinued operations, net
  - 
  5,152 
 
    
    
Net loss
 $(33,316)
 $(11,378)
 
    
    
Basic and diluted earnings (loss) per common share:
    
    
Loss from continuing operations
 $(0.61)
 $(0.37)
Earnings from discontinued operations
 $- 
 $0.11 
 
    
    
Basic and diluted loss per common share
 $(0.61)
 $(0.26)
 
    
    
Basic and diluted weighted average common shares outstanding
  55,006 
  44,599 

 
See Notes to Consolidated Financial Statements in Part II of ChromaDex's Annual Report on Form 10-K filed with Securities and Exchange Commission on March 7, 2019.
 
 
 
-6-